Aurora Cannabis (NASDAQ:ACB) Share Price Breaks Below 50 Day Moving Average - Here's Why

Aurora Cannabis logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Aurora Cannabis shares fell 3.2% and slipped below their 50-day moving average of $4.30, trading as low as $4.26.
  • Analyst sentiment is mostly cautious: one analyst rates the stock Buy, two Hold and two Sell, giving it a MarketBeat consensus rating of “Reduce.”
  • Institutional investors own 47.63% of the stock; recent activity included K2 Principal Fund establishing a new position worth about $5.1 million.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $4.30 and traded as low as $4.26. Aurora Cannabis shares last traded at $4.26, with a volume of 913,118 shares trading hands.

Wall Street Analyst Weigh In

ACB has been the topic of several recent analyst reports. Zacks Research downgraded Aurora Cannabis from a "strong-buy" rating to a "hold" rating in a report on Monday, October 5th. Weiss Ratings upgraded Aurora Cannabis from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, October 2nd. TD Securities cut Aurora Cannabis from a "strong-buy" rating to a "strong sell" rating in a research report on Tuesday, November 3rd. BMO Capital Markets upgraded shares of Aurora Cannabis to a "hold" rating in a research note on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Aurora Cannabis from a "sell" rating to a "hold" rating in a report on Sunday, September 13th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce".

Check Out Our Latest Report on ACB

Aurora Cannabis Stock Down 3.2%

The company has a current ratio of 5.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.03. The company has a market cap of $279.97 million, a price-to-earnings ratio of -4.35 and a beta of 0.65. The firm's fifty day moving average price is $4.30 and its 200-day moving average price is $3.59.

Hedge Funds Weigh In On Aurora Cannabis

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACB. K2 Principal Fund L.P. bought a new position in Aurora Cannabis during the third quarter worth about $5,062,000. Tidal Investments LLC lifted its holdings in Aurora Cannabis by 1.2% during the 2nd quarter. Tidal Investments LLC now owns 1,264,494 shares of the company's stock worth $3,528,000 after buying an additional 14,827 shares during the period. Toronto Dominion Bank bought a new stake in shares of Aurora Cannabis in the 3rd quarter valued at $244,000. JW Asset Management LLC acquired a new stake in shares of Aurora Cannabis in the 3rd quarter valued at about $156,000. Finally, Baader Bank Aktiengesellschaft boosted its holdings in Aurora Cannabis by 37.3% in the first quarter. Baader Bank Aktiengesellschaft now owns 33,060 shares of the company's stock worth $108,000 after acquiring an additional 8,990 shares in the last quarter. 47.63% of the stock is owned by institutional investors.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2006, it grows, processes and sells cannabis products, with a primary focus on medical cannabis and additional sales in Canada's adult-use market. The company's products include dried cannabis flower, oils and other cannabis-based formats. Aurora markets products under brands such as Aurora, MedReleaf and San Rafael '71, and supplies medical cannabis to patients and customers in Canada and international markets, including parts of Europe and Australia.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aurora Cannabis Right Now?

Before you consider Aurora Cannabis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.

While Aurora Cannabis currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines